the aid library

LIST OPTIONS

Filter

6081

Download (159)

View PDF (295)

Commonly abused drugs and withdrawal symptoms

National Institute on Drug Abuse (2019) C2

Accessed: 22.03.2019

Download (677)

View PDF (1580)

Information for Ill Travelers: Ebola What you need to do (for travelers with Ebola symptoms)

Centers for Disease Control and Prevention CDC (2014)

For use with travelers who may have symptoms consistent with Ebola and were recently in an area affected by an Ebola outbreak, but have no other known exposures

Download (75)

View PDF (66)

Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study

Asher, I.; Rutter, C.E.; Bissell, K. et al. The Lancet (2021) CC

Asthma is the most common chronic disease in children globally. The Global Asthma Network (GAN) Phase I study aimed to determine if the worldwide burden of asthma symptoms is changing. This updated cross-sectional study used the same methods as the International study of Asthma and Allergies in Chi...ldhood (ISAAC) Phase III. Asthma symptoms were assessed from centres that completed GAN Phase I and ISAAC Phase I (1993–95), ISAAC Phase III (2001–03), or both. We included individuals from two age groups (children aged 6–7 years and adolescents aged 13–14 years) who self-completed written questionnaires at school. We estimated the 10-year rate of change in prevalence of current wheeze, severe asthma symptoms, ever having asthma, exercise wheeze, and night cough (defined by core questions in the questionnaire) for each centre, and we estimated trends across world regions and income levels using mixed-effects linear regression models with region and country income level as confounders. Overall, 119 795 participants from 27 centres in 14 countries were included: 74 361 adolescents (response rate 90%) and 45 434 children (response rate 79%). About one in ten individuals of both age groups had wheeze in the preceding year, of whom almost half had severe symptoms. Most centres showed a change in prevalence of 2 SE or more between ISAAC Phase III to GAN Phase I. Over the 27-year period (1993–2020), adolescents showed a significant decrease in percentage point prevalence per decade in severe asthma symptoms (–0·37, 95% CI –0·69 to –0·04) and an increase in ever having asthma (1·25, 0·67 to 1·83) and night cough (4·25, 3·06 to 5·44), which was also found in children (3·21, 1·80 to 4·62). The prevalence of current wheeze decreased in low-income countries (–1·37, –2·47 to –0·27], in children and –1·67, –2·70 to –0·64, in adolescents) and increased in lower-middle-income countries (1·99, 0·33 to 3·66, in children and 1·69, 0·13 to 3·25, in adolescents), but it was stable in upper-middle-income and high-income countries. Trends in prevalence and severity of asthma symptoms over the past three decades varied by age group, country income, region, and centre. The high worldwide burden of severe asthma symptoms would be mitigated by enabling access to effective therapies for asthma. more

Download (199)

View PDF (220)

Conventional and and atypical antipsychotics & antidepressant (trazodone) for behavioural and psychological symptoms in people with dementia

World Health Organization (2012) C_WHO

Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?

Download (1166)

View PDF (892)

Effect of Perceived Social Support, Depression Symptoms, and Stigma on Adherence and Treatment Outcome of Highly Active Antiretroviral Therapy at Zewditu Memorial Hospital, Addis Ababa, Ethiopia

Alemu Tilahun, H. (2012) C1

Dissertation

Download (686)

View PDF (1655)

Conditional Release Card: For travelers without symptoms potentially exposed to patients with Ebola

Centers for Disease Control and Prevention CDC (2014)

Possible Exposure: Ebola: What you need to do

Download (152)

View PDF (192)

Asymptomatic, Pre-symptomatic and Mild Signs and Symptoms of COVID-19
recommended

World Health Organization WHO; Regional Office for Africa (2020) C_WHO

Risk Communication and Community Engagement messages

Download (62)

View PDF (59)

Type 1 Daibetes - The big 3 Symptoms

Diabetes.co.uk. the global diabetes community (2024) CC2

Type 1 Daibetes - The big 3 Symptoms - Poster experiencing these symptoms? see a doctor

Download (64)

View PDF (56)

Household biomass fuel use, asthma symptoms severity, and asthma underdiagnosis in rural schoolchildren in Nigeria: a cross-sectional observational study

Oluwole, O.; Arinola, G.O.; Hou, D.; Olopade, C.O. (2017) CC2

In 2014, the International Study of Asthma and Allergies in Childhood (ISAAC) reported that the highest prevalence of symptoms of severe asthma was found in the low- and middle-income countries (LMICs), including Nigeria. While exposure to biomass fuel use may be an important risk factor in the deve... more

Download (92)

View PDF (86)

Diabetes Poster - Do you have any of these symptoms?

Diabetes.co.uk. the global diabetes community (2024) CC2

Diabetes Poster - Do you have any of these symptoms?

Download (80)

View PDF (84)

Diabetes Poster - Does your child show any of these symptoms?

Drugs for Neglected Diseases initiative DNDi (2024) CC2

Diabetes Poster - Does your child show any of these symptoms?

Download (188)

View PDF (254)

COVID-19 in Latin America and the caribbean region: Symptoms and morbidities in the epidemiology of infection

Anaya-Covarrubias, J.Y.; et al. (2022) C1

Curr Opin Pharmacol . 2022 Apr;63:102203.doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11. The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected... more

Download (95)

View PDF (168)

10 Things you can do to manage your Covid-19 Symptoms at Home (Kreyol aysiyen)

Centers for Disease Control and Prevention CDC (2021) C_CDC

10 BAGAY OU K A FÈ POU JERE SENTÒM COVID-19 OU YO L AK AY OU

Download (233)

View PDF (257)

COVID-19 clinical care pathway (‎CARE)‎: confirm SARS-CoV-2 infection, assess symptoms, risk factors and severity, respond with appropriate care and treatment, evaluate clinical response and recovery

World Health Organization WHO (2022) CC

The COVID-19 CARE pathway is a living tool to support health care workers visualize the current clinical and therapeutic recommendations to be considered in the care planning for patients with COVID-19. The COVID-19 CARE pathway is aligned with the eighth version of the WHO Therapeutics and COVID... more

External Link

Interim Recommendations for Cleaning Houses Safely in West Africa Ebola-Affected Areas after Persons with Symptoms of Ebola are Transferred to Ebola Treatment Units or Community Care Centers

Centers for Disease Control and Prevention CDC (2014)

Download (170)

View PDF (219)

Providing access to clean water and sharing critical information on the causes, symptoms, and prevention of cholera (Arabic)

UN Children's Fund UNICEF (2022) C_UNICEF

The document focuses on providing access to clean water and educating people about cholera, including its causes, symptoms, and prevention. It discusses the impact of cholera outbreaks, particularly in the Middle East, and highlights the importance of sanitation, hygiene, and proper water treatment ... more

Download (146)

View PDF (190)

Corona Virus Desease - What you need to know

International SOS (2020) C2

Transmission Symptoms Prevention Treatment

External Link

WHO Science in 5: Episode #73 - Monkeypox

World Health Organization WHO (2022) C_WHO

What are the symptoms of monkeypox? Who is at risk and how can we protect ourselves? Why is WHO concerned about it? WHO’s Dr Rosamund Lewis explains in Science in 5.

Download (159)

View PDF (195)

أعراض الكوليرا

UN Children's Fund UNICEF (2022) C_UNICEF

Poster Cholera Symptoms

External Link

Science in 5 Episode #22 - Children & COVID-19

World Health Organization WHO (2021) CC

Are the symptoms of COVID-19 different in children? Do the new variants impact children differently? What can parents do to keep children safe from COVID-19. WHO's Dr Maria Van Kerkhove explains in Science in 5. Science in 5 is WHO’s conversations in science. Watch WHO experts explain science... more

Asymptomatic, Pre-symptomatic and Mild Signs and Symptoms of COVID-19 recommended

Asymptomatic, Pre-symptomatic and Mild Signs and Symptoms of COVID-19
recommended